about
In-Cell Activation of Organo-Osmium(II) Anticancer Complexes.Ferrocenyl Quinone Methide-Thiol Adducts as New Antiproliferative Agents: Synthesis, Metabolic Formation from Ferrociphenols, and Oxidative Transformation.Enantiomeric-Enriched Ferrocenes: Synthesis, Chiral Resolution, and Mathematic Evaluation of CD-chiral Selector Energies with Ferrocene-Conjugates.Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel.Structurally related hydrazone-based metal complexes with different antitumor activities variably induce apoptotic cell death.Sedaxicenes: potential new antifungal ferrocene-based agents?Antimicrobial activity of organometallic isonicotinyl and pyrazinyl ferrocenyl-derived complexes.Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs.Synthesis and in vitro Biological Evaluation of Ferrocenyl Side-Chain-Functionalized Paclitaxel Derivatives.Ferroquine, the next generation antimalarial drug, has antitumor activity.A ferrocene∩europium assembly showing phototriggered anticancer activity and fluorescent modality imaging.Cymantrenyl-Nucleobases: Synthesis, Anticancer, Antitrypanosomal and Antimicrobial Activity Studies.Antibacterial Properties of Metallocenyl-7-ADCA Derivatives and Structure in Complex with CTX-M β-Lactamase.Coordination-Driven Self-Assembly and Anticancer Potency Studies of Ruthenium-Cobalt-Based Heterometallic Rectangles.Synthesis and structure analysis of ferrocene-containing pseudopeptides.Control over cyclisation sequences of 1,1'-bifunctional octamethylferrocenes to ferrocenophanes.1H-1,2,3-triazole-tethered uracil-ferrocene and uracil-ferrocenylchalcone conjugates: Synthesis and antitubercular evaluation.A new generation of ferrociphenols leads to a great diversity of reactive metabolites, and exhibits remarkable antiproliferative properties.Tamoxifen-like metallocifens target the thioredoxin system determining mitochondrial impairment leading to apoptosis in Jurkat cells.Crystal structure of (E)-1,2-diferrocenyl-1,2-bis(furan-2-yl)ethene.Probing the Anticancer Action of Novel Ferrocene Analogues of MNK InhibitorsFerrocene-Containing Impiridone (ONC201) Hybrids: Synthesis, DFT Modelling, In Vitro Evaluation, and Structure⁻Activity RelationshipsRelevance of Copper and Organic Cation Transporters in the Activity and Transport Mechanisms of an Anticancer Cyclometallated Gold(III) Compound in Comparison to CisplatinCymantrene, Cyrhetrene and Ferrocene Nucleobase Conjugates: Synthesis, Structure, Computational Study, Electrochemistry and Antitrypanosomal Activity
P2860
Q33626165-E6A800B2-7F98-4C7B-887D-9AEA9BD36750Q36045117-50123D82-C528-4732-AC8B-0ECCA05474EFQ38608403-1C0F422F-FBDD-41EA-945E-2F6459A803BAQ38665011-5B2A0098-F7F7-415B-B92D-6D5BF8D79821Q38710830-66DA6178-B914-491F-A136-439FF1912B0EQ38787319-EC7F6A98-1730-402D-B8C0-5BF1B863AA85Q41912333-D06521F9-9CED-45B8-9D40-FEEB1C12E0C5Q46289988-21E01A53-69E8-4A27-9856-484F3E5F95E2Q46302107-2FC878F6-9DED-4106-820F-415E27EA8CE0Q47098598-AED87E8E-E3C9-46A2-8A16-238839238A47Q47194731-77B340CD-C819-41D2-9E5A-730768F6F5A0Q47250020-3C9DF525-F40E-4885-8EC8-A519581F9948Q47626240-B484DA64-AD59-420B-87B9-AFA1AAC1E06DQ48053815-74C8BA7C-83E4-429F-A25E-4472CAD03376Q48147716-A7825BC8-0EAE-4BEF-AD5C-5A44A20215E1Q48308024-7F5BB56A-4B88-478F-AF7F-DCE46103D0C6Q51098218-09F24F34-7CDC-4559-9852-4A9A648DA655Q52599610-CA2117BE-D0C0-44B3-8621-7471E6EC0714Q53745075-5A57C823-C5A0-4F88-936D-CDA1AA0DF095Q55344843-279824A4-077D-4588-BF15-1029F24BB466Q58691921-A96C6444-8D40-4A8A-AC3A-E90EB7180498Q58696201-8AA63EF4-235D-42A8-81D4-C5BBADE14281Q58764839-62D5FA6F-A3BE-4593-8D63-6284C4A32970Q58854970-68676C6A-DE60-4C63-B28C-56C1DE2FB282
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Ferrocifen type anti cancer drugs.
@en
type
label
Ferrocifen type anti cancer drugs.
@en
prefLabel
Ferrocifen type anti cancer drugs.
@en
P2860
P356
P1476
Ferrocifen type anti cancer drugs.
@en
P2093
P2860
P304
P356
10.1039/C5CS00486A
P577
2015-10-21T00:00:00Z